The origin and diversity of the HIV-1 pandemic.

This review examines the enormous progress that has been made in the past decade in understanding the origin of HIV, HIV genetic variability, and the impact of global HIV diversity on the pandemic. Multiple zoonotic transmissions of simian immunodeficiency virus (SIV) have resulted in different HIV lineages in humans. In addition, the high mutation and recombination rates during viral replication result in a great genetic variability of HIV within individuals, as well as within populations, upon which evolutionary selection pressures act. The global HIV pandemic is examined in the context of HIV evolution, and the global diversity of HIV subtypes and recombinants is discussed in detail. Finally, the impact of HIV diversity on pathogenesis, transmission, diagnosis, treatment, the immune response, and vaccine development is reviewed.

[1]  T. F. Rinke de Wit,et al.  Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype C. , 2001, AIDS research and human retroviruses.

[2]  T. Quinn,et al.  Recombinant Viruses and Early Global HIV-1 Epidemic , 2004, Emerging infectious diseases.

[3]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[4]  Bette Korber,et al.  Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine , 2007, PloS one.

[5]  A. Lapedes,et al.  Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.

[6]  H. Romero,et al.  Description of the first full-length HIV type 1 subtype F1 strain in Argentina: implications for the origin and dispersion of this subtype in South America. , 2007, AIDS research and human retroviruses.

[7]  Steven Wolinsky,et al.  Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 , 2008, Nature.

[8]  M. Thomson,et al.  HIV Type 1 molecular epidemiology in cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms. , 2006, AIDS research and human retroviruses.

[9]  Martine Peeters,et al.  Hybrid Origin of SIV in Chimpanzees , 2003, Science.

[10]  Brian T. Foley,et al.  HIV-1 Subtype and Circulating Recombinant Form (CRF) Reference Sequences, 2005 , 2005 .

[11]  Oliver Laeyendecker,et al.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. , 2010, AIDS research and human retroviruses.

[12]  K. Kristiansen,et al.  Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. , 2008, AIDS research and human retroviruses.

[13]  Y. Takebe,et al.  On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China , 2002, AIDS.

[14]  Amilcar Tanuri,et al.  Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. , 2004, AIDS research and human retroviruses.

[15]  Lynn Morris,et al.  Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration , 2005, PLoS medicine.

[16]  Rebecca R. Gray,et al.  Spatial phylodynamics of HIV-1 epidemic emergence in east Africa , 2009, AIDS.

[17]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[18]  Lawrence Corey,et al.  Dual HIV-1 infection associated with rapid disease progression , 2004, The Lancet.

[19]  R. Powell,et al.  High Frequency of HIV-1 Dual Infections Among HIV-Positive Individuals in Cameroon, West Central Africa , 2009, Journal of acquired immune deficiency syndromes.

[20]  F. Brun-Vézinet,et al.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O , 1998, Nature Medicine.

[21]  O. Pybus,et al.  Temporal and Spatial Dynamics of Human Immunodeficiency Virus Type 1 Circulating Recombinant Forms 08_BC and 07_BC in Asia , 2008, Journal of Virology.

[22]  P. Lemey,et al.  The Molecular Population Genetics of HIV-1 Group O , 2004, Genetics.

[23]  C. Brennan,et al.  Confirmation of Putative HIV-1 Group P in Cameroon , 2010, Journal of Virology.

[24]  B. Coulibaly,et al.  Diversity of HIV in Rural Burkina Faso , 2006, Journal of acquired immune deficiency syndromes.

[25]  Tulio de Oliveira,et al.  High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania , 2008, PloS one.

[26]  K Bebenek,et al.  The accuracy of reverse transcriptase from HIV-1. , 1988, Science.

[27]  B. Korber,et al.  An African HIV-1 sequence from 1959 and implications for the origin of the epidemic , 1998, Nature.

[28]  Todd M. Allen,et al.  HIV-1 adaptation to NK cell mediated immune pressure , 2011, Nature.

[29]  Alan S. Perelson,et al.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.

[30]  A. Rambaut,et al.  The emergence of HIV/AIDS in the Americas and beyond , 2007, Proceedings of the National Academy of Sciences.

[31]  Cynthia A. Derdeyn,et al.  Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 , 2009, PLoS pathogens.

[32]  Oliver Laeyendecker,et al.  Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.

[33]  E. Sanders-Buell,et al.  Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. , 2008, Virology.

[34]  Punnee Pitisuttithum,et al.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. , 2006, The Journal of infectious diseases.

[35]  B. Korber,et al.  Evolutionary and immunological implications of contemporary HIV-1 variation. , 2001, British medical bulletin.

[36]  P. Sharp,et al.  AIDS as a zoonosis: scientific and public health implications. , 2000, Science.

[37]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[38]  Hui Li,et al.  Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users , 2010, Journal of Virology.

[39]  David Heckerman,et al.  HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering , 2009, Journal of Virology.

[40]  A. Kamarulzaman,et al.  Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia , 2005, AIDS.

[41]  Oliver Laeyendecker,et al.  HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda , 2009, AIDS.

[42]  P. Kaleebu,et al.  Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. , 2002, The Journal of infectious diseases.

[43]  Mi-Suk Kim,et al.  Timing and evolution of the most recent common ancestor of the Korean clade HIV subtype B based on Nef and Vif sequences , 2009, The Journal of Microbiology.

[44]  Jaap Goudsmit,et al.  Recent Evolutionary History of Human Immunodeficiency Virus Type 1 Subtype B: Reconstruction of Epidemic Onset Based on Sequence Distances to the Common Ancestor , 2002, Journal of Molecular Evolution.

[45]  C. Brennan,et al.  The Prevalence of Diverse HIV-1 Strains Was Stable in Cameroonian Blood Donors From 1996 to 2004 , 2008, Journal of acquired immune deficiency syndromes.

[46]  J. Overbaugh,et al.  No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. , 2005, AIDS research and human retroviruses.

[47]  D. Eric,et al.  Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[48]  E. Bunnik,et al.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.

[49]  M. Peeters,et al.  Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[50]  Bette Korber,et al.  Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys , 2010, Nature Medicine.

[51]  Ron Diskin,et al.  Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.

[52]  C. McArthur,et al.  Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. , 2010, AIDS research and human retroviruses.

[53]  M. Suchard,et al.  Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[54]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[55]  P. Ghys,et al.  Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.

[56]  François Simon,et al.  Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N , 2004, AIDS.

[57]  David L. Robertson,et al.  Human immunodeficiency virus: Phylogeny and the origin of HIV-1 , 2001, Nature.

[58]  M. Peeters,et al.  Evidence of stable HIV seroprevalences in selected populations in the Democratic Republic of the Congo , 1998, AIDS.

[59]  O. Pybus,et al.  Estimating the date of origin of an HIV-1 circulating recombinant form. , 2009, Virology.

[60]  U. Alam,et al.  Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans , 2003, AIDS.

[61]  P. Lemey,et al.  Quantifying Differences in the Tempo of Human Immunodeficiency Virus Type 1 Subtype Evolution , 2009, Journal of Virology.

[62]  P. Van de Perre,et al.  Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study. , 2010, Journal of virological methods.

[63]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[64]  J. Baeten,et al.  Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population , 2004, AIDS.

[65]  A. Ayouba,et al.  HIV-1 group O infection in Cameroon, 1986 to 1998. , 2001, Emerging infectious diseases.

[66]  O. Laeyendecker,et al.  HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  C. McArthur,et al.  HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. , 2004, AIDS research and human retroviruses.

[68]  V. Veloso,et al.  Genetic characterization of HIV-1 BC recombinants and evolutionary history of the CRF31_BC in Southern Brazil. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[69]  R. Kantor.  Impact of HIV-1 pol diversity on drug resistance and its clinical implications , 2006, Current opinion in infectious diseases.

[70]  P. Sharp,et al.  Human immunodeficiency viruses: SIV infection in wild gorillas , 2006, Nature.

[71]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[72]  R. Swanstrom,et al.  Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.

[73]  M. Peeters,et al.  Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. , 2008, AIDS research and human retroviruses.

[74]  K. Strimmer,et al.  Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolution , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  L. Wain,et al.  Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 , 2006, Science.

[76]  D. Palmer,et al.  Human immunodeficiency virus. , 1990, Journal of the American Podiatric Medical Association.

[77]  D. Heckerman,et al.  Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections , 2007, Journal of Virology.

[78]  Allen G. Rodrigo,et al.  Testing the Hypothesis of a Recombinant Origin of Human Immunodeficiency Virus Type 1 Subtype E , 2000, Journal of Virology.

[79]  Vincent Moulton,et al.  Identifying recombinants in human and primate immunodeficiency virus sequence alignments using quartet scanning , 2009, BMC Bioinformatics.

[80]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[81]  M. Peeters,et al.  Characterization of a Highly Replicative Intergroup M/O Human Immunodeficiency Virus Type 1 Recombinant Isolated from a Cameroonian Patient , 1999, Journal of Virology.

[82]  Anne Piantadosi,et al.  Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection , 2007, PLoS pathogens.

[83]  M. Peeters,et al.  Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon , 2009, PloS one.

[84]  Anne-Mieke Vandamme,et al.  Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form , 2007, Journal of Virology.

[85]  D. Rousset,et al.  Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun , 2010, Journal of acquired immune deficiency syndromes.

[86]  T. de Oliveira,et al.  Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe , 2009, AIDS.

[87]  Joel O. Wertheim,et al.  Dating the Age of the SIV Lineages That Gave Rise to HIV-1 and HIV-2 , 2009, PLoS Comput. Biol..

[88]  G. Bello,et al.  Origin and evolutionary history of HIV-1 subtype C in Brazil , 2008, AIDS.

[89]  Ming Zhang,et al.  HIV classification using the coalescent theory , 2010, Bioinform..

[90]  C. Brennan,et al.  Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters. , 2002, AIDS research and human retroviruses.

[91]  N. Sewankambo,et al.  Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda , 2007, AIDS.

[92]  M. Thomson,et al.  High Prevalence of Unique Recombinant Forms of HIV-1 in Ghana: Molecular Epidemiology From an Antiretroviral Resistance Study , 2008, Journal of acquired immune deficiency syndromes.

[93]  P. Easterbrook,et al.  Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy , 2010, Journal of the International AIDS Society.

[94]  Sergei L. Kosakovsky Pond,et al.  Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  Oliver G Pybus,et al.  Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. , 2009, Virology.

[96]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[97]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[98]  O. Laeyendecker,et al.  HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda , 2009, Journal of acquired immune deficiency syndromes.

[99]  G. Learn,et al.  Origin and Biology of Simian Immunodeficiency Virus in Wild-Living Western Gorillas , 2008, Journal of Virology.

[100]  François Simon,et al.  A new human immunodeficiency virus derived from gorillas , 2009, Nature Medicine.

[101]  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981 .

[102]  W. Fawzi,et al.  Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  C. Gray,et al.  Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. , 2004, The Journal of infectious diseases.

[104]  Simon A. A. Travers,et al.  Timing and Reconstruction of the Most Recent Common Ancestor of the Subtype C Clade of Human Immunodeficiency Virus Type 1 , 2004, Journal of Virology.

[105]  Martine Peeters,et al.  Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa , 2000, Journal of Virology.

[106]  Bhavna Chohan,et al.  HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. , 2007, The Journal of infectious diseases.

[107]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[108]  J. Goudsmit,et al.  Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification , 2001, AIDS.

[109]  James Theiler,et al.  Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains , 2010, Nature Medicine.

[110]  D. Posada,et al.  Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba , 2005, AIDS.

[111]  F. Kirchhoff.  Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. , 2010, Cell host & microbe.

[112]  Feng Gao,et al.  Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.

[113]  F. Gao,et al.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes , 1999, Nature.